|
BUYINS.NET: (IDXX) SqueezeTrigger Price is $49.759. There is
$276,275,700.00 That Short Sellers Still Need To Cover
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:15072008
BUYINS.NET / www.squeezetrigger.com is monitoring IDEXX Laboratories
Inc (NASDAQ:IDXX) in real time and just received an alert that is
crossing above its primary SqueezeTrigger Price, the price that a short
squeeze can start in any stock. There are 5503500 shares that have been
shorted at the volume weighted average SqueezeTrigger Price of $49.759.
To access SqueezeTrigger Prices ahead of potential short squeezes
beginning, visit http://www.squeezetrigger.com .
From January 2005 to June 2008, an aggregate amount of 47232770 shares
of IDXX have been shorted for a total dollar value of
$2,314,405,730.00. The IDXX SqueezeTrigger price of $49.759 is the
volume weighted average price that all shorts are short in shares of
IDXX. There is still approximately $276,275,700.00 of potential short
covering in shares of IDXX.
SqueezeTrigger.com has built a massive database that collects, analyzes
and publishes a proprietary SqueezeTrigger Price for each stock that
has been shorted. The data has then been integrated into an automated
trading platform which can be used to connect to a live online broker
and automate your trading of short squeeze events. It is extremely
powerful with lightening fast execution at a very low price. Both the
trading software and SqueezeTrigger data feed are available at
http://www.squeezetrigger.com .
IDEXX Laboratories Inc (NASDAQ:IDXX) IDEXX Laboratories, Inc. (IDEXX),
incorporated in 1983, develops, manufactures and distributes products
and provides services for the veterinary, and the food and water
testing markets. The Company's products and services include
point-of-care veterinary diagnostic products, comprising rapid assays,
and instruments and instrument consumables; laboratory and consulting
services used by veterinarians; veterinary pharmaceutical products;
information products and services, and digital radiography systems for
veterinarians; diagnostic and health-monitoring products for production
animals; products that test water for certain microbiological
contaminants, and products that test milk for antibiotic residues.
IDEXX operates primarily through three business segments: products and
services for the veterinary market, which the Company refers to as
Companion Animal Group; water quality products (Water), and products
for production animal health and dairy quality, which it refers to as
the Food Diagnostics Group.
Companion Animal Group
IDEXX provides a range of single-use, hand-held test kits for a variety
of companion animal diseases and health conditions. The Company's
principal single-use tests are sold under the SNAP name, and include a
feline combination test, the SNAP Combo FIV antibody/FeLV antigen test,
which enables veterinarians to test simultaneously for feline
immunodeficiency virus (FIV) (which is similar to the human acquired
immunodeficiency syndrome (AIDS) virus) and feline leukemia virus
(FeLV); a canine combination test, the SNAP 3Dx, which tests
simultaneously for Lyme disease, Ehrlichia canis and heartworm; a
canine heartworm-only test, and canine and feline tests for Giardia, a
parasitic disease. In addition to the Company's single-use tests, it
sells a line of microwell-based test kits, under the PetChek name,
which are used by larger clinics and independent laboratories to test
multiple samples. It sells PetChek tests for FeLV, FIV and canine
heartworm disease.
IDEXX markets several instrument systems, as well as associated
consumable products, for use in veterinary clinics. The Company's
VetTest blood and urine chemistry analyzer is used to measure levels of
certain enzymes and other substances in blood or urine in order to
assist the veterinarian in diagnosing physiologic conditions. The
VetTest also runs tests for urine protein/urine creatinine ratio, which
assists in the detection of early renal disease.
IDEXX purchases all of the reagents used in the VetTest analyzer (dry
chemistry slides or VetTest slides) from Ortho-Clinical Diagnostics,
Inc. (Ortho), a subsidiary of Johnson & Johnson. In October 2003,
the Company entered into a new agreement with Ortho under which it is
developing a next-generation chemistry analyzer for the veterinary
market based on Ortho's dry-slide technology, and Ortho will supply the
slide consumables used in both the VetTest analyzer and the new
analyzer through 2018. IDEXX sells two hematology analyzers: the
LaserCyte system, which uses laser-flow cytometry technology to analyze
components of blood, including red blood cells, white blood cells, and
platelets, and the QBC VetAutoread hematology analyzer.
The Company's VetLyte system measures three electrolytes, sodium,
potassium and chloride, to aid in evaluating acid-base and electrolyte
balances and assessing plasma hydration. Test results are available in
less than one minute after sample introduction and are either displayed
on the VetLyte analyzer or downloaded to the VetTest analyzer. Its
VetStat analyzer, which it expects to introduce in 2005, measures
electrolytes, blood gases, acid-base balance, glucose and ionized
calcium, and calculates other parameters, such as bicarbonate and anion
gap.
The VetTest SNAP Reader allows the veterinarian to obtain quantitative
measurement of hormones, including thyroxine (T4) and cortisol. These
measurements assist in diagnosing and monitoring the treatment of
certain endocrine diseases, such as hyper- and hypothyroidism,
Cushing's syndrome and Addison's disease.
The SqueezeTrigger database of approximately 1 billion short sale
transactions goes back to January 1, 2005 and calculates the exact
price at which the Total Short Interest is short in each stock. This
data was never before available prior to January 1, 2005 because the
Self Regulatory Organizations (primary exchanges) guarded it
aggressively. After the SEC passed Regulation SHO, exchanges were
forced to allow data processors like SqueezeTrigger.com to access the
data. Total Short Interest is the number of shares shorted but not yet
covered, and is different from total short volume. To access
SqueezeTrigger Prices ahead of potential short squeezes beginning,
visit http://www.squeezetrigger.com
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide
shareholders of publicly traded US companies fight short selling.
SqueezeTrigger.com has built a proprietary database that uses Threshold
list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE
to generate detailed and useful information to combat the short selling
problem. For the first time, actual trade by trade data is available to
the public that shows the attempted size, actual size, price and
average value of short sales in stocks that have been shorted. This
information is valuable in determining the precise point at which short
sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes
and publishes a proprietary SqueezeTrigger for each stock that has been
shorted. The SqueezeTrigger database of nearly one billion short sale
transactions goes back to January 1, 2005 and calculates the exact
price at which the Total Short Interest is short in each stock. This
data was never before available prior to January 1, 2005 because the
Self Regulatory Organizations (primary exchanges) guarded it
aggressively. After the SEC passed Regulation SHO, exchanges were
forced to allow data processors like SqueezeTrigger.com to access the
data.
The SqueezeTrigger database collects individual short trade data on
over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on
nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows
by approximately 50,000,000 short sale transactions and provides
investors with the knowledge necessary to time when to buy and sell
stocks with outstanding short positions. By tracking the size and price
of each month's short transactions, SQUEEZETRIGGER.COM provides
institutions, traders, analysts, journalists and individual investors
the exact price point where short sellers start losing money and a
short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon
information believed to be reliable. The information contained herein
is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not
be considered to be all-inclusive. The companies that are discussed in
this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information
provided in reports issued by BUYINS.NET, a company affiliated with
SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This
opinion contains forward-looking statements that involve risks and
uncertainties. This material is for informational purposes only and
should not be construed as an offer or solicitation of an offer to buy
or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker
dealer, market maker, investment banker, investment advisor, analyst or
underwriter. Please consult a broker before purchasing or selling any
securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not
advise as to when it decides to sell and does not and will not offer
any opinion as to when others should sell; each investor must make that
decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock
market professionals. As a member, visitor, or user of any kind, you
accept full responsibilities for your investment and trading actions.
The contents of SQUEEZETRIGGER.COM, including but not limited to all
implied or expressed views, opinions, teachings, data, graphs,
opinions, or otherwise are not predictions, warranty, or endorsements
of any kind. Please seek stock market advice from the proper securities
professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree
to assume full responsibility for the decisions or actions that you
undertake. Global Automated Trading Systems, LLC, its owner(s),
operators, employees, partners, affiliates, advertisers, information
providers and any other associated person or entity, shall under no
circumstances be held liable to the user and/or any third party for
loss or damages of any kind, including but not limited to trading
losses, lost trading opportunity, direct, indirect, consequential,
special, incidental, or punitive damages. As a user, you agree that any
damages collected shall not exceed the amount paid to
SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that
any and all legal matters of any kind are to be reviewed and handled in
their entirety within the State of California only. By using the
services of this website, you are consenting to the terms as outlined,
and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all
examples are hypothetical and should not be considered a guarantee or
endorsement of such trading activity. SQUEEZETRIGGER.COM does not take
responsibility for problems of any kind, including but not limited to
issues with operations, data accuracy or completeness, contacting
issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places
great integrity on the data collected and distributed. This information
is deemed reliable, but not guaranteed. All information and data is
provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or
services from a securities professional. You should consider these
factors in evaluating the forward-looking statements included herein,
and not place undue reliance on such statements. The forward-looking
statements in this release are made as of the date hereof and
SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may", "future", "plan" or "planned", "will" or "should", "expected,"
"anticipates", "draft", "eventually" or "projected". You are cautioned
that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking
statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies'
annual report on Form 10-K or 10-KSB and other filings made by such
company with the SEC.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
CONTACT: Thomas Ronk, CEO, SqueezeTrigger.com
Tel: +1 800 715 9999
e-mail: Tom@SqueezeTrigger.com
WWW: http://www.SqueezeTrigger.com
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To it.tmcnet.com's Homepage ]
|